Abstract
The etiology of type 2 diabetes mellitus involves the induction of insulin resistance along with the disruption of pancreatic β-cell function and the loss of β-cell mass. In addition to a genetic predisposition, lifestyle factors seem to have an important role. Epidemiological studies indicate that the increased presence of endocrine disrupting chemicals (EDCs) in the environment may also play an important part in the incidence of metabolic diseases. Widespread EDCs, such as dioxins, pesticides and bisphenol A, cause insulin resistance and alter β-cell function in animal models. These EDCs are present in human blood and can accumulate in and be released from adipocytes. After binding to cellular receptors and other targets, EDCs either imitate or block hormonal responses. Many of them act as estrogens in insulin-sensitive tissues and in β cells, generating a pregnancy-like metabolic state characterized by insulin resistance and hyperinsulinemia. Adult exposure in mice produces insulin resistance and other metabolic alterations; in addition, during pregnancy, EDCs alter glucose metabolism in female mice, as well as glucose homeostasis and endocrine pancreatic function in offspring. Although more experimental work is necessary, evidence already exists to consider exposure to EDCs as a risk factor in the etiology of type 2 diabetes mellitus and other diseases related to insulin resistance.
Key Points
-
The prevalence of type 2 diabetes mellitus (T2DM) has increased dramatically worldwide, making the disease one of the fastest growing public health problems
-
The etiology of T2DM is based on the induction of insulin resistance together with functional disruption of insulin producing β cells; genetic predisposition and environmental factors play key roles
-
Some widespread endocrine disrupting chemicals (EDCs), at concentrations found in human plasma, induce insulin resistance and alter pancreatic β-cell function in cellular and adult animal models
-
Epidemiological data indicate that exposure to EDCs is linked to an increased risk of diabetes mellitus in adults
-
Data obtained from pregnant mice and offspring indicate that short exposure to the EDC bisphenol A during pregnancy disrupts glucose homeostasis in female mice and their adult male offspring
-
Sufficient scientific evidence is available to consider the exposure to persistent organic pollutants, including bisphenol A, a risk factor for T2DM and other metabolic disorders
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
International Programme for Chemical Safety (IPCS) in Global assessment of the state-of-the-science of endocrine disruptors. Chapter 1: Executive Summary, 1–3 [online], (2010).
International Programme on Chemical Safety (IPCS). Global assessment of the state-of-the-science of endocrine disruptors [online], (2010).
Porta, M. et al. Distribution of blood concentrations of persistent organic pollutants in a representative sample of the population of Catalonia. Environ. Int. 36, 655–664 (2010).
Darnerud, P. O. et al. POP levels in breast milk and maternal serum and thyroid hormone levels in mother-child pairs from Uppsala, Sweden. Environ. Int. 36, 180–187 (2010).
Calafat, A. M., Wong, L. Y., Ye, X., Reidy, J. A. & Needham, L. L. Concentrations of the sunscreen agent benzophenone-3 in residents of the United States: National Health and Nutrition Examination Survey 2003–2004. Environ. Health Perspect. 116, 893–897 (2008).
Vandenberg, L. N., Hauser, R., Marcus, M., Olea, N. & Welshons, W. V. Human exposure to bisphenol A (BPA). Reprod. Toxicol. 24, 139–177 (2007).
Fernandez, M. F. et al. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod. Toxicol. 24, 259–264 (2007).
Stahlhut, R. W., Welshons, W. V. & Swan, S. H. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect. 117, 784–789 (2009).
Taylor, J. A. et al. Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure. Environ. Health Perspect. doi:10.1289/ehp.1002514.
Biddinger, S. B. & Kahn, C. R. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68, 123–158 (2006).
Wild, S., Roglic, G., Green, A., Sicree, R. & King, H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053 (2004).
Reaven, G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595–1607 (1988).
Herman, M. A. & Kahn, B. B. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J. Clin. Invest. 116, 1767–1775 (2006).
Ropero, A. B., Alonso-Magdalena, P., Quesada, I. & Nadal, A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids 73, 874–879 (2008).
Rosen, E. D. & Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847–853 (2006).
Fritsche, L., Weigert, C., Häring, H. U. & Lehmann, R. How insulin receptor substrate proteins regulate the metabolic capacity of the liver--implications for health and disease. Curr. Med. Chem. 15, 1316–1329 (2008).
Rhodes, C. J. Type 2 diabetes—a matter of beta-cell life and death? Science 307, 380–384 (2005).
Kahn, S. E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46, 3–19 (2003).
Beard, J. C., Ward, W. K., Halter, J. B., Wallum, B. J. & Porte, D. Jr. Relationship of islet function to insulin action in human obesity. J. Clin. Endocrinol. Metab. 65, 59–64 (1987).
Lazar, M. A. How obesity causes diabetes: not a tall tale. Science 307, 373–375 (2005).
Virtue, S. & Vidal-Puig, A. It's not how fat you are, it's what you do with it that counts. PLoS Biol. 6, e237 (2008).
Utzschneider, K. M. et al. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes. Obesity (Silver Spring) 18, 1781–1787 (2010).
Wildman, R. P. et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch. Intern. Med. 168, 1617–1624 (2008).
Alonso-Magdalena, P., Morimoto, S., Ripoll, C., Fuentes, E. & Nadal, A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 114, 106–112 (2006).
Alonso-Magdalena, P. et al. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ. Health Perspect. 118, 1243–1250 (2010).
Ruzzin, J. et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ. Health Perspect. 118, 465–471 (2010).
Enan, E., Liu, P. C. & Matsumura, F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig. J. Biol. Chem. 267, 19785–19791 (1992).
Novelli, M., Piaggi, S. & De Tata, V. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced impairment of glucose-stimulated insulin secretion in isolated rat pancreatic islets. Toxicol. Lett. 156, 307–314 (2005).
Kurita, H. et al. Aryl hydrocarbon receptor-mediated effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on glucose-stimulated insulin secretion in mice. J. Appl. Toxicol. 29, 689–694 (2009).
Ishida, T. et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced change in intestinal function and pathology: evidence for the involvement of arylhydrocarbon receptor-mediated alteration of glucose transportation. Toxicol. Appl. Pharmacol. 205, 89–97 (2005).
Weber, L. W. et al. Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology 66, 133–144 (1991).
Nadal, A. et al. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc. Natl Acad. Sci. USA 97, 11603–11608 (2000).
Rorsman, P. et al. The cell physiology of biphasic insulin secretion. News Physiol. Sci. 15, 72–77 (2000).
Quesada, I. et al. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. FASEB J. 16, 1671–1673 (2002).
Alonso-Magdalena, P. et al. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ. Health Perspect. 113, 969–977 (2005).
Quesada, I., Tudurí, E., Ripoll, C. & Nadal, A. Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J. Endocrinol. 199, 5–19 (2008).
Ropero, A. B. et al. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int. J. Androl. 31, 194–200 (2008).
US Environmental Protection Agency Integrated Risk Information System [online], (2010).
European Food Safety Authority Bisphenol A [online], (2010).
Weltje, L., vom Saal, F. S. & Oehlmann, J. Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptative response. Hum. Exp. Toxicol. 24, 431–437 (2005).
Alonso-Magdalena, P. et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 3, e2069 (2008).
Adachi, T. et al. Promoting insulin secretion in pancreatic islets by means of bisphenol A and nonylphenol via intracellular estrogen receptors. Food Chem. Toxicol. 43, 713–719 (2005).
Hugo, E. R. et al. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 116, 1642–1647 (2008).
Whitehead, J. P., Richards, A. A., Hickman, I. J., Macdonald, G. A. & Prins, J. B. Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes. Metab. 8, 264–280 (2006).
Masuno, H., Iwanami, J., Kidani, T., Sakayama, K. & Honda, K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol. Sci. 84, 319–327 (2005).
Wada, K. et al. Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome. J. Pharmacol. Sci. 105, 133–137 (2007).
Phrakonkham, P. et al. Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J. Steroid Biochem. Mol. Biol. 110, 95–103 (2008).
Kidani, T. et al. Bisphenol A downregulates Akt signaling and inhibits adiponectin production and secretion in 3T3-L1 adipocytes. J. Atheroscler. Thromb. 17, 834–843 (2010).
Grün, F. et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol. Endocrinol. 20, 2141–2155 (2006).
Zuo, Z. et al. Tributyltin causes obesity and hepatic steatosis in male mice. Environ. Toxicol. 26, 79–85 (2011).
Jimenez-Chillaron, J. C. et al. Beta-cell secretory dysfunction in the pathogenesis of low birth weight-associated diabetes: a murine model. Diabetes 54, 702–711 (2005).
Jimenez-Chillaron, J. C. et al. Intergenerational transmission of glucose intolerance and obesity by in utero undernutrition in mice. Diabetes 58, 460–468 (2009).
Newbold, R. R., Padilla-Banks, E. & Jefferson, W. N. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147 (Suppl.), S11–S17 (2006).
Newbold, R. R., Padilla-Banks, E. & Jefferson, W. N. Environmental estrogens and obesity. Mol. Cell. Endocrinol. 304, 84–89 (2009).
Rubin, B. S., Murray, M. K., Damassa, D. A., King, J. C. & Soto, A. M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 109, 675–680 (2001).
Rubin, B. S. & Soto, A. M. Bisphenol A: Perinatal exposure and body weight. Mol. Cell. Endocrinol. 304, 55–62 (2009).
Howdeshell, K. L., Hotchkiss, A. K., Thayer, K. A., Vandenbergh, J. G. & vom Saal, F. S. Exposure to bisphenol A advances puberty. Nature 401, 763–764 (1999).
Somm, E. et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 117, 1549–1555 (2009).
Ryan, K. K. et al. Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 151, 2603–2612 (2010).
Sharpe, R. M. & Drake, A. J. Bisphenol a and metabolic syndrome. Endocrinology 151, 2404–2407 (2010).
Kirchner, S., Kieu, T., Chow, C., Casey, S. & Blumberg, B. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes. Mol. Endocrinol. 24, 526–539 (2010).
Kuiper, G. G. et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863–870 (1997).
Kuiper, G. G. et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252–4263 (1998).
Sheeler, C. Q., Dudley, M. W. & Khan, S. A. Environmental estrogens induce transcriptionally active estrogen receptor dimers in yeast: activity potentiated by the coactivator RIP140. Environ. Health Perspect. 108, 97–103 (2000).
vom Saal, F. S. & Hughes, C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 113, 926–933 (2005).
Diamanti-Kandarakis, E. et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr. Rev. 30, 293–342 (2009).
Wozniak, A. L., Bulayeva, N. N. & Watson, C. S. Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environ. Health Perspect. 113, 431–439 (2005).
Ropero, A. B., Alonso-Magdalena, P., Ripoll, C., Fuentes, E. & Nadal, A. Rapid endocrine disruption: environmental estrogen actions triggered outside the nucleus. J. Steroid Biochem. Mol. Biol. 102, 163–169 (2006).
Silva, E., Kabil, A. & Kortenkamp, A. Cross-talk between non-genomic and genomic signalling pathways—distinct effect profiles of environmental estrogens. Toxicol. Appl. Pharmacol. 245, 160–170 (2010).
Swedenborg, E., Pongratz, I. & Gustafsson, J. A. Endocrine disruptors targeting ERbeta function. Int. J. Androl. 33, 288–297 (2010).
Barros, R. P., Machado, U. F. & Gustafsson, J. A. Estrogen receptors: new players in diabetes mellitus. Trends Mol. Med. 12, 425–431 (2006).
Nadal, A., Alonso-Magdalena, P., Soriano, S., Quesada, I. & Ropero, A. B. The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol. Cell. Endocrinol. 304, 63–68 (2009).
Sorenson, R. L. & Brelje, T. C. Prolactin receptors are critical to the adaptation of islets to pregnancy. Endocrinology 150, 1566–1569 (2009).
Nadal, A., Alonso-Magdalena, P., Soriano, S., Ropero, A. B. & Quesada, I. The role of oestrogens in the adaptation of islets to insulin resistance. J. Physiol. 587, 5031–5037 (2009).
Alonso, A. et al. 17beta-estradiol treatment is unable to reproduce p85 alpha redistribution associated with gestational insulin resistance in rats. J. Steroid Biochem. Mol. Biol. 116, 160–170 (2009).
Barros, R. P., Gabbi, C., Morani, A., Warner, M. & Gustafsson, J. A. Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue. Am. J. Physiol. Endocrinol. Metab. 297, E124–E133 (2009).
Soriano, S. et al. Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. Mol. Endocrinol. 23, 1973–1982 (2009).
Wong, W. P. et al. Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc. Natl Acad. Sci. USA 107, 13057–13062 (2010).
Wetherill, Y. B. et al. In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. 24, 178–198 (2007).
Swedenborg, E. & Pongratz, I. AhR and ARNT modulate ER signaling. Toxicology 268, 132–138 (2010).
Pascussi, J. M. et al. The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu. Rev. Pharmacol. Toxicol. 48, 1–32 (2008).
Thackaberry, E. A. et al. Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females. Toxicol. Sci. 76, 407–417 (2003).
Bertazzi, P. A. et al. Health effects of dioxin exposure: a 20-year mortality study. Am. J. Epidemiol. 153, 1031–1044 (2001).
Henriksen, G. L., Ketchum, N. S., Michalek, J. E. & Swaby, J. A. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8, 252–258 (1997).
Kern, P. A., Said, S., Jackson, W. G. Jr & Michalek, J. E. Insulin sensitivity following agent orange exposure in Vietnam veterans with high blood levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Clin. Endocrinol. Metab. 89, 4665–4672 (2004).
Michalek, J. E. & Pavuk, M. Diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia. J. Occup. Environ. Med. 50, 330–340 (2008).
Lee, D. H. et al. A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999–2002. Diabetes Care 29, 1638–1644 (2006).
Lee, D. H., Lee, I. K., Jin, S. H., Steffes, M. & Jacobs, D. R. Jr. Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999–2002. Diabetes Care 30, 622–628 (2007).
Lee, D. H., Lee, I. K., Porta, M., Steffes, M. & Jacobs, D. R. Jr. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999–2002. Diabetologia 50, 1841–1851 (2007).
Lee, D. H. et al. Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case–control study. Environ. Health Perspect. 118, 1235–1242 (2010).
Lang, I. A. et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300, 1303–1310 (2008).
Melzer, D., Rice, N. E., Lewis, C., Henley, W. E. & Galloway, T. S. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS ONE 5, e8673 (2010).
Kortenkamp, A., Faust, M., Scholze, M. & Backhaus, T. Low-level exposure to multiple chemicals: reason for human health concerns? Environ. Health Perspect. 115 (Suppl. 1), 106–114 (2007).
Ghisari, M. & Bonefeld-Jorgensen, E. C. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions. Toxicol. Lett. 189, 67–77 (2009).
Soto, A. M. & Sonnenschein, C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat. Rev. Endocrinol. 6, 363–370 (2010).
Acknowledgements
The authors laboratories are funded by “Ministerio de Ciencia e Innovación” and “Generalitat Valenciana”. CIBERDEM is an initiative of “Instituto de Salud Carlos III”. The authors thank Elaine Vieira, Sergi Soriano, Laura Marroquí and Esther Fuentes for critical reading of the manuscript. We thank the members of our laboratories for their continuous input and discussion.
Author information
Authors and Affiliations
Contributions
P. Alonso-Magdalena and A. Nadal contributed to researching data for the article, all authors provided a substantial contribution to the discussion of content, A. Nadal wrote the article and all authors reviewed/edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Alonso-Magdalena, P., Quesada, I. & Nadal, A. Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol 7, 346–353 (2011). https://doi.org/10.1038/nrendo.2011.56
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2011.56
This article is cited by
-
Association of maternal exposure to endocrine disruptor chemicals with cardio-metabolic risk factors in children during childhood: a systematic review and meta-analysis of cohort studies
Diabetology & Metabolic Syndrome (2024)
-
Die Rolle von Fast Food als Nährboden für das metabolische Syndrom
Info Diabetologie (2023)
-
Exposure to Endocrine-Disrupting Chemicals and Type 2 Diabetes Mellitus in Later Life
Exposure and Health (2023)
-
Quantitative structure–activity relationship modeling of hydroxylated polychlorinated biphenyls as constitutive androstane receptor agonists
Structural Chemistry (2023)
-
Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis
Environmental Health (2022)